Steroids in Occipital Nerve Block for Treatment of Headache

Overview

About this study

The primary purpose of this study is to compare the effectiveness of dexamethasone with local anesthetic versus local anesthetic alone in occipital nerve blocks for treatment of headache.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • ≥ 18 years of age.
  • Treated for headache including, but not limited to, occipital neuralgia, episodic migraine, chronic migraine and/or cervicogenic headache.
  • Stable on preventative medication dosing for at least 1 month prior to occipital nerve block and no change in preventative medication regimen during the course of the study.
  • Able to understand the requirements of the study and return for treatment.
  • Able to independently provide informed consent.

Exclusion Criteria:

  • Diagnosis of cluster headache according to the International Classification of Headache Disorders 3rd edition.
  • Occipital or other cranial nerve block administered within 3 months prior to initiation of study.
  • History of adverse reaction or contraindication to any of the study ingredients (bupivacaine, lidocaine, dexamethasone), including pregnancy.
  • Infection or bleeding at site of injection.
  • Cranial bone or cervical spine defects/prior surgeries near injection site that prohibit use of landmark-based technique.

Eligibility last updated 7/27/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Carrie Robertson, M.D.

Open for enrollment

Contact information:

Carrie Robertson M.D.

(507) 266-3544

Robertson.Carrie@mayo.edu

More information

Publications

Publications are currently not available